Abstract:Stem cells are an essential consideration in the fields of tissue engineering and regenerative medicine. Understanding how nanoengineered biomaterials and mesenchymal stem cells (MSCs) interact is crucial for their role in bone regeneration. Taking advantage of the structural stability of selenium nanoparticles (Se-NPs) and biological properties of natural polymers, Se-NPs-functionalized, injectable, thermoresponsive hydrogels with an interconnected molecular structure were prepared to identify their role in the osteogenic differentiation of different types of mesenchymal stem cells. Further, comprehensive characterization of their structural and biological properties was performed. The results showed that the hydrogels undergo a sol to gel transition with the help of β-glycerophosphate, while functionalization with Se-NPs significantly enhances their biological response through stabilizing their polymeric structure by forming Se-O covalent bonds. Further results suggest that Se-NPs enhance the differentiation of MSCs toward osteogenic lineage in both the 2D as well as 3D. We demonstrated that the Se-NPs-functionalized hydrogels could enhance the differentiation of osteoporotic bone-derived MSCs. We also focused on specific cell surface marker expression (CD105, CD90, CD73, CD45, CD34) based on the exposure of healthy rats' bone marrow-derived stem cells (BMSCs) to the Se-NP-functionalized hydrogels. This study provides essential evidence for pre-clinical/clinical applications, highlighting the potential of the nanoengineered biocompatible elastic hydrogels for bone regeneration in diseased bone.

Correction: Selenium nanoparticle-functionalized injectable chitosan/collagen hydrogels as a novel therapeutic strategy to enhance stem cell osteoblastic differentiation for bone regeneration

Correction: A Novel Biocompatible, Simvastatin-Loaded, Bone-Targeting Lipid Nanocarrier for Treating Osteoporosis More Effectively

Corrigendum to 'Injectable and high-strength PLGA/CPC loaded ALN/MgO bone cement for bone regeneration by facilitating osteogenesis and inhibiting osteoclastogenesis in osteoporotic bone defects' [Mater. Today Bio 26, June 2024, 101092]

Correction: A biotin-stabilized HKUST-1/ADM scaffold for facilitating MSC endothelial differentiation and vascularization in diabetic wound healing

Correction: 45S5 bioactive glass-based scaffolds coated with cellulose nanowhiskers for bone tissue engineering

Correction: Bioactive SiO<sub>2</sub>@Ru nanoparticles for osteogenic differentiation of mesenchymal stem cells via activation of Akt signaling pathways

Correction: Transgenic PDGF-BB/sericin Hydrogel Supports for Cell Proliferation and Osteogenic Differentiation

Erratum: Simvastatin/hydrogel-loaded 3D-printed titanium alloy scaffolds suppress osteosarcoma via TF/NOX2-associated ferroptosis while repairing bone defects.

Correction: A Vessel Subtype Beneficial for Osteogenesis Enhanced by Strontium-Doped Sodium Titanate Nanorods by Modulating Macrophage Polarization

Corrigendum: Micro-Nano Bioactive Glass Particles Incorporated Porous Scaffold for Promoting Osteogenesis and Angiogenesis in vitro

Correction: Chondroitin Sulfate-Polydopamine Modified Polyethylene Terephthalate with Extracellular Matrix-Mimetic Immunoregulatory Functions for Osseointegration.

Correction: Bioactive SiO2@Ru nanoparticles for osteogenic differentiation of mesenchymal stem cells via activation of Akt signaling pathways.

Correction: Enhancing Osteogenic Differentiation of MC3T3-E1 Cells During Inflammation Using UPPE/β-TCP/TTC Composites Via the Wnt/β-catenin Pathway

Alginate/Gelatin Hydrogel Scaffold Containing nCeO2 as a Potential Osteogenic Nanomaterial for Bone Tissue Engineering [Corrigendum]

Corrigendum to “3D-Printed Tri-Element-doped Hydroxyapatite/ Polycaprolactone Composite Scaffolds with Antibacterial Potential for Osteosarcoma Therapy and Bone Regeneration” [bioact. Mater. 31 (january 2024) 18–37]

Correction: Modulated Podosome Patterning in Osteoclasts by Fullerenol Nanoparticles Disturbs the Bone Resorption for Osteoporosis Treatment.

Corrigendum to “dual Aldehyde Cross-Linked Hyaluronic Acid Hydrogels Loaded with PRP and NGF Biofunctionalized PEEK Interfaces to Enhance Osteogenesis and Vascularization” [mater. Today Bio 24 (2024) 100928]

Correction: Centimeter-sized biomimetic bone constructs fabricated via CBD-BMP2-collagen microcarriers and BMSC-gelatin microspheres

Correction: Core–shell bioceramic fiber-derived biphasic granules with adjustable core compositions for tuning bone regeneration efficacy

Selenium nanoparticle-functionalized injectable chitosan/collagen hydrogels as a novel therapeutic strategy to enhance stem cell osteoblastic differentiation for bone regeneration

Author Correction: Enhancing Cell Proliferation and Osteogenic Differentiation of MC3T3-E1 Pre-osteoblasts by BMP-2 Delivery in Graphene Oxide-Incorporated PLGA/HA Biodegradable Microcarriers